Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

November 2004 - Part 1

A Review of Fibromyalgia

ByDevi E. Nampiaparampil, MD,Robert H. Shmerling, MD

November 1st 2004

Appropriateness of NSAID and Coxib Prescribing for Patients With Osteoarthritis by Primary Care Physicians in Ontario: Results From the CANOAR Study

ByRolf J. Sebaldt, MD,Annie Petrie, BSc,Charles H. Goldsmith, PhD,Michael A. Marentette, MBA

November 1st 2004

Matching Patients and Practitioners Based on Beliefs About Care: Results of a Randomized Controlled Trial

ByEdward Krupat, PhD,John Hsu, MD, MBA, MSCE,Julie Irish, PhD,Julie A. Schmittdiel, MA,Joe Selby, MD, MPH

November 1st 2004

Systematic Reviews for Evidence-based Management: How to Find Them and What to Do With Them

ByKitty S. Chan, PhD,Sally C. Morton, PhD,Paul G. Shekelle, MD, PhD

November 1st 2004

A Randomized Study to Decrease the Use of Potentially Inappropriate Medications Among Community-dwelling Older Adults in a Southeastern Managed Care Organization

ByDonna M. Fick, PhD, RN,J. Ross Maclean, MD,Nancy A. Rodriguez, RN,Louise Short, MD, MSc,Richard Vanden Heuvel, MPA,Jennifer L. Waller, PhD,Rebecca L. Rogers, PhD

November 1st 2004

COX-2 Inhibitor Use After Vioxx: Careful Balance or End of the Rope?

ByA. Mark Fendrick, MD

November 1st 2004

Measuring Patient Safety in Ambulatory Care: Potential for Identifying Medical Group Drug"Drug Interaction Rates Using Claims Data

ByLeif I. Solberg, MD,Judith S. Hurley, MS, RD,Melissa H. Roberts, MS,Winnie W. Nelson, PharmD, MS,Floyd J. Frost, PhD,A. Lauren Crain, PhD,Margaret J. Gunter, PhD,Linda R. Young, PharmD

November 1st 2004

Correspondence regarding, "Potential Application of the National Kidney Foundation's Chronic Kidney Disease Guidelines in a Managed Care Setting"

ByBrian J. Lee, MD, Alan Lau, MD,Ken Forbes,Author reply by Micah L. Thorp, DO, MPH

November 1st 2004

Identifying Controlled Substance Patterns of Utilization Requiring Evaluation Using Administrative Claims Data

ByStephen T. Parente, PhD,Susan S. Kim, PharmD,Michael D. Finch, PhD,Lisa A. Schloff, MS,Thomas S. Rector, PharmD, PhD,Raafat Seifeldin, PharmD, PhD,J. David Haddox, DDS, MD

November 1st 2004

Trending on AJMC

Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

5 Ongoing Clinical Trials in Myeloproliferative Neoplasms

Defunding Co-Payment Assistance Disrupted nAMD Care

Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM